Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025
-
Cardinals to vote anew for pope after second black smoke
-
Arsenal fall short again as striker woes haunt Arteta
-
Inter turn attentions to fading Serie A title defence after Barca triumph
-
Elk could return to UK after 3,000 years as plan wins funding
-
Trump announces 'full and comprehensive' trade deal with UK
-
Putin and Xi rail against West as Ukraine reports truce violations
-
England's Itoje to captain British and Irish Lions rugby team in Australia
-
Gates Foundation to spend $200 bn through 2045 when it will shut down
-
Swiatek makes fast start at Italian Open
-
Israel's aid blockade to Gaza 'unacceptable': Red Cross
-
EU threatens to target US cars, planes if Trump tariff talks fail
-
Amnesty says UAE supplying Sudan paramilitaries with Chinese weapons
-
Bank of England cuts interest rate as US tariffs hit economy
-
Germany slams Russian 'lies' on Ukraine in WWII commemoration
-
Pakistan and India accuse each other of waves of drone attacks
-
Thrilling PSG home in on elusive Champions League trophy
-
Wolf protection downgrade gets green light in EU
-
Fijian Olympic medallist Raisuqe killed after car hit by train
-
EU parliament backs emissions reprieve for carmakers
-
Trump announces trade agreement with UK
-
Global temperatures stuck at near-record highs in April: EU monitor
-
Stocks rise as Trump signals US-UK 'trade deal'
-
Second black smoke, cardinals to vote again for new pope
-
Screams and shattered glass under Pakistan bombardment
-
Drone strikes spark civilian exodus from army-controlled Sudan aid hub
-
First responders in Gaza run out of supplies
-
Pakistan shoots down 25 Indian drones near military installations
-
Xi meets Putin in Moscow as Ukraine reports truce violations
-
Israel forces close UN schools in annexed east Jerusalem
-
Trump to announce 'trade deal' with UK
-
'Jumbo': the animated Indonesian film smashing records
-
Stocks rise on trade hopes, London boosted by reports of deal
-
Emirates airline group announces record $6.2 bn gross profit
-
Accused mushroom murderer sent children to movies before deadly meal
-
Nintendo forecasts 15 million Switch 2 sales in 2025-26
-
Australian Greens chief loses his own seat
-
Toyota cites tariffs as it forecasts 35% net profit drop
-
Wolf protection downgrade set for green light in EU
-
Global cult following keeps Le Creuset simmering
-
Austria's JJ makes operatic pop soar at Eurovision
-
Toyota cites tariffs as it forecasts 35% drop in 2025-26 net profit
-
Depoliticising Eurovision 'impossible', experts say
-
Trump official to unveil ambitious US air traffic control upgrade
-
India and Pakistan trade fire after deadly escalation
-
Knicks rally again to take 2-0 lead over Celtics, Thunder roar back
-
What the shell: scientists marvel as NZ snail lays egg from neck
-
Eurovision week's opening parade set to start the party
-
Trump to announce trade deal with UK on Thursday: US media
-
Dhoni says 'nothing to decide now' over retirement plans
-
A bitter return for Iraqis kicked out of Europe
NYSE - LSE
Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025
CAMBRIDGE, MA / ACCESS Newswire / May 8, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference:
Bernstein's 41st Annual Strategic Decisions Conference (SDC), on Thursday, May 29th at 10:00am ET
A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website.
A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
[email protected]
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
A.Mahlangu--AMWN
